Advertisement

Click here for more guidelines.

 
 




CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1984; 4:812-819
© 1984 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vignola, P.
Right arrow Articles by Lister, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vignola, P.
Right arrow Articles by Lister, J.

Lymphocytic myocarditis presenting as unexplained ventricular arrhythmias: diagnosis with endomyocardial biopsy and response to immunosuppression

PA Vignola, K Aonuma, PS Swaye, JJ Rozanski, RL Blankstein, J Benson, AJ Gosselin, and JW Lister

During a period of 18 months beginning in January 1982, a total of 65 patients were referred to the Miami Heart Institute for evaluation of either aborted out of hospital sudden death, ventricular tachycardia resistant to standard clinically directed antiarrhythmic medication programs or high grade ventricular arrhythmia (Lown class greater than or equal to IV B) with or without syncope. After complete evaluation including cardiac catheterization in all but 1 patient, 17 patients were identified in whom no obvious cardiac disease could be found. Twelve of the 17 underwent right ventricular endomyocardial biopsy. Six of the 12 biopsies demonstrated clinically unsuspected lymphocytic myocarditis (Group A). Findings in three of the remaining six biopsies were consistent with an early cardiomyopathy and in three were completely normal (Group B). Retrospective review of the clinical, laboratory, electrophysiologic, hemodynamic and angiographic data failed to identify a marker that reliably separated Group A from Group B patients. In addition to antiarrhythmic therapy guided by laboratory electrophysiologic study, all Group A patients were treated with prednisone and azathioprine. After 6 months of immunosuppression, all patients with myocarditis were reevaluated in the hospital without antiarrhythmic medication. Ventricular tachycardia/fibrillation could not be provoked in the laboratory during repeat electrophysiologic testing in five of the six patients. Repeat myocardial biopsy after all immunosuppressive therapy had been discontinued revealed absence of inflammation associated with varying degrees of residual interstitial fibrosis. There were no deaths. It was concluded that a patient with an otherwise clinically silent lymphocytic myocarditis can present with potentially life-threatening ventricular arrhythmias.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
Eur Heart JHome page
H.-P. Schultheiss, U. Kuhl, and L. T. Cooper
The management of myocarditis
Eur. Heart J., November 1, 2011; 32(21): 2616 - 2625.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
L. T. Cooper, K. L. Baughman, A. M. Feldman, A. Frustaci, M. Jessup, U. Kuhl, G. N. Levine, J. Narula, R. C. Starling, J. Towbin, et al.
The role of endomyocardial biopsy in the management of cardiovascular disease: A Scientific Statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology
Eur. Heart J., December 2, 2007; 28(24): 3076 - 3093.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
L. T. Cooper, K. L. Baughman, A. M. Feldman, A. Frustaci, M. Jessup, U. Kuhl, G. N. Levine, J. Narula, R. C. Starling, J. Towbin, et al.
The Role of Endomyocardial Biopsy in the Management of Cardiovascular Disease: A Scientific Statement From the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology
J. Am. Coll. Cardiol., November 6, 2007; 50(19): 1914 - 1931.
[Full Text] [PDF]


Home page
CirculationHome page
L. T. Cooper, K. L. Baughman, A. M. Feldman, A. Frustaci, M. Jessup, U. Kuhl, G. N. Levine, J. Narula, R. C. Starling, J. Towbin, et al.
The Role of Endomyocardial Biopsy in the Management of Cardiovascular Disease: A Scientific Statement From the American Heart Association, the American College of Cardiology, and the European Society of Cardiology
Circulation, November 6, 2007; 116(19): 2216 - 2233.
[Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
C P P Hia, W C L Yip, B C Tai, and S C Quek
Immunosuppressive therapy in acute myocarditis: an 18 year systematic review
Arch. Dis. Child., June 1, 2004; 89(6): 580 - 584.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H. L. Kennedy
Ventricular ectopy in athletes: Don't worry ... more good news!
J. Am. Coll. Cardiol., August 7, 2002; 40(3): 453 - 456.
[Full Text] [PDF]


Home page
HeartHome page
A D'Ambrosio, G Patti, A Manzoli, G Sinagra, A Di Lenarda, F Silvestri, and G Di Sciascio
The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review
Heart, May 1, 2001; 85(5): 499 - 504.
[Full Text]


Home page
HeartHome page
K J Lee, B W McCrindle, D J Bohn, G J Wilson, G P Taylor, R M Freedom, J F Smallhorn, and L N Benson
Clinical outcomes of acute myocarditis in childhood
Heart, August 1, 1999; 82(2): 226 - 233.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
R. Brooks, B. A. McGovern, H. Garan, and J. N. Ruskin
Current Treatment of Patients Surviving Out-of-Hospital Cardiac Arrest
JAMA, February 13, 1991; 265(6): 762 - 768.
[Abstract] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement